Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

I. Sekine1* Y. Ichinose2 Y. Nishiwaki3 N. Yamamoto4 M. Tsuboi5 K. Nakagawa6 T. Shinkai7 S. Negoro8 F. Imamura9 K. Eguchi10 K. Takeda11 Y. Itoh12 T. Tamura1 N. Saijo3 and M. Fukuoka6

首页> 外文期刊>Annals of Oncology >Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

【24h】

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

机译：先前接受过治疗的日本非小细胞肺癌患者的生活质量和与疾病相关的症状：吉非替尼与多西他赛的一项随机III期研究（V-15-32）结果

获取原文

获取原文并翻译 | 示例

获取外文期刊封面目录资料

开具论文收录证明 >>

文献代查 >>

文献数据库（团队版） >>

页面导航

摘要
著录项
引文网络
相似文献
相关主题

摘要

Background: This report describes quality of life (QoL) findings of a randomized study comparing gefitinib with docetaxel in patients with advanced/metastatic pretreated non-small-cell lung cancer.

机译：背景：本报告描述了一项吉非替尼与多西紫杉醇对晚期/转移性非小细胞肺癌患者的生活质量（QoL）研究结果。

著录项

来源
《Annals of Oncology》 |2009年第9期|p.1483-1488|共6页
作者
I. Sekine1* Y. Ichinose2 Y. Nishiwaki3 N. Yamamoto4 M. Tsuboi5 K. Nakagawa6 T. Shinkai7 S. Negoro8 F. Imamura9 K. Eguchi10 K. Takeda11 Y. Itoh12 T. Tamura1 N. Saijo3 and M. Fukuoka6;
展开▼
作者单位

1Division of Internal Medicine and Thoracic Oncology, National Cancer Center Hospital, Tokyo 2Department of Thoracic Oncology, National Kyushu Cancer Center, Fukuoka 3Department of Thoracic Oncology, National Cancer Center Hospital East, Chiba 4Division of Thoracic Oncology, Shizuoka Cancer Center, Shizuoka 5Department of Thoracic Surgery and Oncology, Tokyo Medical University Hospital, Tokyo 6Department of Medical Oncology, Kinki University School of Medicine, Osaka 7Department of Internal Medicine, Respiratory Division, NHO Shikoku Cancer Center, Ehime 8Department of Thoracic Oncology, Hyogo Cancer Center, Hyogo 9Department of Pulmonary Oncology, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka 10Department of Internal Medicine and Medical Oncology, Teikyo;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词

相似文献

外文文献
中文文献
专利

1. Phase III study, V-15-32, of gefitinib versus docetaxel in previously treated Japanese patients with non-small-cell lung cancer. [J] . Maruyama R, Nishiwaki Y, Tamura T, Journal of Clinical Oncology . 2008,第26期

机译：吉非替尼与多西他赛在先前治疗的日本非小细胞肺癌患者中进行的III期研究V-15-32。
2. Symptom and quality of life benefit of afatinib in advanced non-small-cell lung cancer patients previously treated with erlotinib or gefitinib: Results of a randomized phase iib/iii trial (lux-lung 1) [J] . HirshV., CadranelJ., CongX.J., Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2013,第2期

机译：阿法替尼在先前接受厄洛替尼或吉非替尼治疗的晚期非小细胞肺癌患者中的症状和生活质量改善：一项IIb / iii期随机试验的结果（勒克斯-肺1）
3. Quality of life assessment of second-line docetaxel versus best supportive care in patients with non-small-cell lung cancer previously treated with platinum-based chemotherapy: results of a prospective, randomized phase III trial. [J] . Dancey J, Shepherd FA, Gralla RJ, Lung cancer: Journal of the International Association for the Study of Lung Cancer . 2004,第2期

机译：先前接受铂类化学疗法治疗的非小细胞肺癌患者二线多西紫杉醇与最佳支持治疗的生活质量评估：一项前瞻性，随机III期试验的结果。
4. Pemetrexed versus docetaxel single agent chemotherapy in chemotherapy-naive elderly patients with advanced non-small cell lung cancer [C] . Hua Xin, Zhenguo Han, Haibo Huang 2011 International Conference on Human Health and Biomedical Engineering . 2011

机译：培美曲塞与多西他赛单药化疗在未接受化疗的老年晚期非小细胞肺癌患者中的作用
5. The effectiveness of chemoradiation for stage III non-small-cell lung cancer patients at the Kingston Regional Cancer Center (Ontario). [D] . Sinclair, Suzanne Marie. 2003

机译：金斯敦地区癌症中心（安大略省）对III期非小细胞肺癌患者进行化学放射治疗的有效性。
6. A randomized phase III trial of oral S-1 plus cisplatin versus docetaxel plus cisplatin in Japanese patients with advanced non-small-cell lung cancer: TCOG0701 CATS trial [O] . K. Kubota, H. Sakai, N. Katakami, -1

机译：TCOG0701 CATS试验在日本晚期非小细胞肺癌患者中口服S-1加顺铂与多西他赛加顺铂进行的随机III期试验：
7. B3-01: A randomized Phase III study to compare the overall survival of gefitinib (IRESSA) versus docetaxel in Japanese patients with previously treated advanced non-small-cell lung cancer [O] . Sekine Ikuo, Ichinose Yukito, Nishiwaki Yutaka, 2007

机译：B3-01：一项随机III期研究，比较吉非替尼（IRESSA）与多西他赛在日本先前接受过治疗的晚期非小细胞肺癌患者中的总体生存率

Quality of life and disease-related symptoms in previously treated Japanese patients with non-small-cell lung cancer: results of a randomized phase III study (V-15-32) of gefitinib versus docetaxel

摘要

著录项

引文网络

相似文献

相关主题

期刊订阅